Aflac Incorporated $AFL Shares Sold by Creekmur Asset Management LLC

Creekmur Asset Management LLC lowered its position in shares of Aflac Incorporated (NYSE:AFL) by 28.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,330 shares of the financial services provider’s stock after selling 3,392 shares during the quarter. Creekmur Asset Management LLC’s holdings in Aflac were worth $878,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in AFL. Brighton Jones LLC grew its holdings in shares of Aflac by 64.4% during the fourth quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 5,708 shares in the last quarter. Bison Wealth LLC grew its holdings in shares of Aflac by 4.3% during the fourth quarter. Bison Wealth LLC now owns 4,402 shares of the financial services provider’s stock worth $455,000 after buying an additional 183 shares in the last quarter. Diversified Trust Co purchased a new stake in shares of Aflac during the first quarter worth $200,000. Golden State Wealth Management LLC grew its holdings in shares of Aflac by 121.9% during the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider’s stock worth $34,000 after buying an additional 167 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Aflac by 1.0% during the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 60,391 shares of the financial services provider’s stock worth $6,715,000 after buying an additional 578 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Price Performance

AFL stock opened at $106.78 on Friday. The business has a fifty day moving average of $108.63 and a two-hundred day moving average of $105.62. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.33. The stock has a market cap of $57.11 billion, a price-to-earnings ratio of 24.21, a price-to-earnings-growth ratio of 2.93 and a beta of 0.86. Aflac Incorporated has a 52-week low of $96.95 and a 52-week high of $115.43.

Aflac (NYSE:AFL) last posted its earnings results on Monday, February 27th. The financial services provider reported $1.07 earnings per share (EPS) for the quarter. The company had revenue of $5.91 billion during the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%. As a group, research analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 2nd. Shareholders of record on Wednesday, August 20th were paid a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Wednesday, August 20th. Aflac’s dividend payout ratio (DPR) is 52.61%.

Aflac declared that its Board of Directors has authorized a stock buyback program on Tuesday, August 12th that authorizes the company to buyback 100,000,000 shares. This buyback authorization authorizes the financial services provider to reacquire shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Morgan Stanley upped their target price on shares of Aflac from $108.00 to $113.00 and gave the stock an “equal weight” rating in a report on Monday, August 18th. Wells Fargo & Company upped their target price on shares of Aflac from $105.00 to $107.00 and gave the stock an “equal weight” rating in a report on Monday, August 11th. UBS Group dropped their target price on shares of Aflac from $114.00 to $111.00 and set a “neutral” rating for the company in a report on Wednesday, August 6th. Evercore ISI set a $110.00 price objective on shares of Aflac and gave the company an “underperform” rating in a report on Thursday, October 9th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Aflac from $96.00 to $100.00 and gave the company a “neutral” rating in a report on Tuesday, July 8th. Three research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Aflac has an average rating of “Hold” and a consensus target price of $109.45.

Insiders Place Their Bets

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $102.57, for a total transaction of $102,570.00. Following the completion of the transaction, the director owned 25,105 shares of the company’s stock, valued at $2,575,019.85. This trade represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.90% of the stock is currently owned by company insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.